Lymph Node Swelling After COVID-19 Vaccination

Introduction to Vaccine-Associated Adenopathy

• The American College of Radiology notes that swollen lymph nodes in the neck are a recognized side effect of the Moderna COVID-19 vaccine, occurring as a normal immune response when the vaccine drains to cervical and supraclavicular lymph nodes 1, 2
• Lymph node enlargement after COVID-19 vaccination is a normal immune response that occurs when locally activated antigens accumulate at the injection site and migrate to draining lymph nodes 1, 3

Clinical Presentation and Epidemiology

• In the Phase 3 trial for Moderna, adenopathy was reported as an unsolicited event in 1.1% of patients 1, 2
• Axillary swelling or tenderness occurred in up to 16.0% in patients aged 18-64 years and up to 8.4% of patients over 65 years of age (compared to 4.3% and 2.5% in placebo groups) 1, 4
• In 0.3-0.6% of patients, symptoms were severe enough to require prescription medicine for relief 1, 4

Timeline and Duration of Adenopathy

• The typical timeline for vaccine-associated lymphadenopathy is predictable and helps distinguish it from other causes: onset within 2-4 days after either dose 1, 4, 5
• Clinical duration averages 1-2 days for Moderna (compared to 10 days for Pfizer-BioNTech) 1, 4
• Imaging findings may persist longer: while clinical symptoms resolve quickly, imaging studies may show persistent adenopathy for weeks to months 1

Management Approach and Red Flags

• For typical vaccine-associated adenopathy presenting within 2-4 days of vaccination, reassurance and observation are appropriate without imaging 5
• Persistent adenopathy beyond 10-14 days warrants ultrasound as the initial imaging modality 5
• High nodal metastatic risk requiring immediate confirmation: tissue biopsy should be considered when immediate histopathologic confirmation is necessary for timely patient management 6, 7

Special Considerations for Cancer Patients

• In patients with cancer history or undergoing cancer surveillance, vaccine-associated adenopathy can mimic metastatic disease, leading to unnecessary biopsies or treatment changes 6, 8, 7
• Schedule routine imaging (screening, surveillance) either before vaccination or at least 6 weeks after the final vaccination dose to allow reactive adenopathy to resolve 3, 8
• Administer the vaccine on the side contralateral to the primary or suspected cancer 3, 4

Documentation and Patient Education

• Vaccination information must be systematically collected and communicated, including date(s) administered, injection site(s) and laterality, and type of vaccine 2, 3
• Patients should be informed that lymph node swelling is an expected immune response as the body develops antibodies to vaccination 7